4//SEC Filing
Brenner Erin K. 4
Accession 0001062993-22-013687
CIK 0001835567other
Filed
May 26, 8:00 PM ET
Accepted
May 27, 4:02 PM ET
Size
7.2 KB
Accession
0001062993-22-013687
Insider Transaction Report
Form 4
Brenner Erin K.
Chief Product Dev. Officer
Transactions
- Exercise/Conversion
Common Stock
2022-05-25$1.00/sh+15,000$15,000→ 15,000 total - Exercise/Conversion
Stock Option (Right to Buy)
2022-05-25−15,000→ 105,234 totalExercise: $1.00Exp: 2028-09-20→ Common Stock (15,000 underlying)
Footnotes (2)
- [F1]25% of the shares underlying the option vested on July 16, 2019 and an additional 2.0833 and 1/3% of the shares vested or shall vest on the last day of each calendar month thereafter.
- [F2]Received in accordance with the terms of the Business Combination Agreement (the "Business Combination Agreement") dated as of June 21, 2021, by and among Thimble Point Acquisition Corp., Oz Merger Sub, Inc. and Pear Therapeutics (US), Inc. (f/k/a Pear Therapeutics, Inc.) ("Private Pear"), in exchange for an option to acquire 81,659 shares of common stock of Private Pear for $1.46 per share.
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001881042
Filing Metadata
- Form type
- 4
- Filed
- May 26, 8:00 PM ET
- Accepted
- May 27, 4:02 PM ET
- Size
- 7.2 KB